Siena, Italy

Nastasja Palombi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitá Degli Studi Di Siena. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nastasja Palombi. Retrieved from https://idiyas.com/inventor/nastasja-palombi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nastasja Palombi: Innovator in Antiviral Compounds

Introduction

Nastasja Palombi is a prominent inventor based in Siena, Italy. She has made significant contributions to the field of medicinal chemistry, particularly in the development of antiviral agents. Her innovative work focuses on creating compounds that can effectively combat diseases caused by enveloped viruses.

Latest Patents

Nastasja holds a patent for "Antiviral compounds and use thereof." This invention relates to compounds of formula (I) and their use as medicaments, specifically as broad-spectrum antiviral agents. The compounds are particularly useful in treating diseases caused by enveloped viruses, showcasing her commitment to advancing medical science.

Career Highlights

Nastasja is affiliated with the Università degli Studi di Siena, where she conducts her research and development. Her work has garnered attention for its potential impact on public health, especially in the context of viral infections.

Collaborations

Nastasja collaborates with esteemed colleagues, including David Lembo and Cristina Tintori. These partnerships enhance her research efforts and contribute to the advancement of antiviral therapies.

Conclusion

Nastasja Palombi's innovative work in antiviral compounds exemplifies her dedication to improving healthcare through scientific research. Her contributions are vital in the ongoing fight against viral diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…